Trial · NCT07389018
Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)
NCT07389018, Not yet recruiting, SYSNAV
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R). Trials, record NCT07389018. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07389018
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)
- NCT number
- NCT07389018
- Status
- Not yet recruiting
- Enrollment
- 30 participants, estimated
- Lead sponsor
- SYSNAV
- Conditions
- Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)
- First posted
- 2026-02-05
- Last updated
- 2026-04-22
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol. | 16 months | Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol (supposed optimal threshold for analysis) at baseline, Month 4, Month 8, Month 12 and Month 16. |
| Primary | French Usability score (F-SUS) at Month 4 and at the end of the study | 16 months | Usability score at Month 4 and Month 16. The System Usability Scale is a 10-item questionnaire . It is a simple tool to measure the usability of an interactive system and it is widely used. For each item, the user is asked to express their level of agreement or disagreement from 1 (strongly disagree) and 5 (strongly agree). |
| Secondary | Change from baseline in the total wearing time at months 4, 8, 12, and 16. | 16 months | Change from baseline in the total wearing time at months 4, 8, 12, and 16. |
| Secondary | Reproducibility of Syde® digital endpoints for each recording period timepoint | 16 months | Reproducibility of Syde® digital endpoints assessed by the ICC (Intra-Class Correlation) and Bland and Altman analysis for each recording period timepoint (baseline, 4 months, 8 months, 12 months, and 16 months) |
| Secondary | Correlation between Syde® digital endpoints and 2-minute walk test (2MWT) | 16 months | Correlation at baseline and at different timepoints between Syde® digital endpoints and 2MWT |
| Secondary | Correlation between Syde® digital endpoints and 10-meter walk test (10MWT) | 16 months | Correlation at baseline and at different timepoints between Syde® digital endpoints and 10MWT |
| Secondary | Correlation between Syde® digital endpoints and Timed Up and Go (TUG) | 16 months | Correlation at baseline and at different timepoints between Syde® digital endpoints and TUG |
| Secondary | Correlation between Syde® digital endpoints and falls reported by the participants | 16 months | Correlation at baseline and at different timepoints between Syde® digital endpoints and falls reported by the participants |
| Secondary | Correlation between Syde® digital endpoints and Progressive Supranuclear Palsy Rating Scale (PSP-RS) | 16 months | Correlation at baseline and at different timepoints between Syde® digital endpoints and PSP-RS |
| Secondary | Correlation between Syde® digital endpoints and Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS) | 16 months | Correlation at baseline and at different timepoints between Syde® digital endpoints and PSP-CDS |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07389018
GET https://conductscience.org/api/trials/v1/NCT07389018/registered